Rapport Therapeutics (RAPP) Change in Acquisitions & Divestments (2024 - 2026)

Rapport Therapeutics (RAPP) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $10.1 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $10.1 million in Q1 2026; TTM through Mar 2026 was $178.0 million, a 13.53% decrease from a year earlier, with the FY2025 full-year figure at $167.9 million, down 19.96% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $10.1 million, down from $22.9 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for RAPP reached as high as $116.7 million in Q4 2024 and fell as low as $3.9 million in Q1 2024.
• Historically, Change in Acquisitions & Divestments has averaged $48.5 million across 3 years, with a median of $38.6 million in 2024.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 209.77% in 2025 and fell as far as 80.37% in 2025.
• Year by year, Change in Acquisitions & Divestments stood at $116.7 million in 2024, then tumbled by 80.37% to $22.9 million in 2025, then slumped by 56.04% to $10.1 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $10.1 million in Q1 2026, $22.9 million in Q4 2025, and $45.0 million in Q3 2025.